Novel brain injury treatment tested in 1st human subject

June 15, 2022

Drug conceived at UT Health San Antonio was safe, effective in animal studies Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO, TEXAS, AND GROTON, CONN. (Wednesday, June 15, 2022) — An experimental brain injury medication conceived in laboratories at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was tested Tuesday, […]

Neuron concept art


UT Health San Antonio offers summer program for people with aphasia

April 26, 2022

Article by Kate Hunger, UT Health San Antonio SAN ANTONIO (April 26, 2022) — The news of actor Bruce Willis’ aphasia diagnosis is drawing attention to a condition that is fairly common but not well understood by the general public. Aphasia is a condition that affects a person’s ability to communicate. People with aphasia can […]

Photo of aphasia therapy



Clot-removal procedures can help more stroke patients than previously thought

December 10, 2021

Study reviewed data from thousands of patients who had mechanical thrombectomy. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 10, 2021) — A study of 2,345 stroke patients, all of whom underwent mechanical thrombectomy to remove blood clots from the brain causing stroke symptoms, found that re-establishing blood flow through this lifesaving procedure may […]

Image of skull and brain of stroke patient


Texas Public Radio: Texas’ new Alzheimer’s research center zeroes in on the disease’s disproportionate impact on Latinos

October 14, 2021

Dr. Sudha Seshadri, Neurology, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was a guest on Texas Public Radio’s “The Source” and discussed how UT Health San Antonio and The University of Texas Rio Grande Valley will work together to address the disproportionate impact of Alzheimer’s in Latinos at a new nationally designated Alzheimer’s Disease […]


Brain injury therapy advancing toward human studies

October 8, 2021

Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug to treat brain injuries such as concussion and stroke.

Neuron concept art